PMID- 32155778 OWN - NLM STAT- MEDLINE DCOM- 20210318 LR - 20240328 IS - 2218-273X (Electronic) IS - 2218-273X (Linking) VI - 10 IP - 3 DP - 2020 Mar 6 TI - A Preliminary Study of Cu Exposure Effects upon Alzheimer's Amyloid Pathology. LID - 10.3390/biom10030408 [doi] LID - 408 AB - A large body of evidence indicates that dysregulation of cerebral biometals (Fe, Cu, Zn) and their interactions with amyloid precursor protein (APP) and Abeta amyloid may contribute to the Alzheimer's disease (AD) Abeta amyloid pathology. However, the molecular underpinnings associated with the interactions are still not fully understood. Herein we have further validated the exacerbation of Abeta oligomerization by Cu and H(2)O(2) in vitro. We have also reported that Cu enhanced APP translations via its 5' untranslated region (5'UTR) of mRNA in SH-SY5Y cells, and increased Abeta amyloidosis and expression of associated pro-inflammatory cytokines such as MCP-5 in Alzheimer's APP/PS1 doubly transgenic mice. This preliminary study may further unravel the pathogenic role of Cu in Alzheimer's Abeta amyloid pathogenesis, warranting further investigation. FAU - Pilozzi, Alexander AU - Pilozzi A AD - Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. FAU - Yu, Zhanyang AU - Yu Z AUID- ORCID: 0000-0003-3787-8127 AD - Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. FAU - Carreras, Isabel AU - Carreras I AD - Department of Veterans Affairs, VA Medical Center, Bedford, MA 01730, USA. AD - Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA. FAU - Cormier, Kerry AU - Cormier K AD - Department of Veterans Affairs, VA Medical Center, Bedford, MA 01730, USA. AD - Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA. FAU - Hartley, Dean AU - Hartley D AD - Autism Speaks, Chicago, IL 60659, USA. FAU - Rogers, Jack AU - Rogers J AD - Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. FAU - Dedeoglu, Alpaslan AU - Dedeoglu A AD - Department of Veterans Affairs, VA Medical Center, Bedford, MA 01730, USA. AD - Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA. FAU - Huang, Xudong AU - Huang X AUID- ORCID: 0000-0002-4811-1901 AD - Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. LA - eng GR - R01 AG056614/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20200306 PL - Switzerland TA - Biomolecules JT - Biomolecules JID - 101596414 RN - 0 (APP protein, human) RN - 0 (APP protein, mouse) RN - 0 (Amyloid beta-Peptides) RN - 0 (Amyloid beta-Protein Precursor) RN - 789U1901C5 (Copper) SB - IM MH - *Alzheimer Disease/genetics/metabolism/pathology MH - *Amyloid beta-Peptides/chemistry/genetics/metabolism MH - *Amyloid beta-Protein Precursor/biosynthesis/chemistry/genetics MH - Animals MH - Cell Line, Tumor MH - Copper/*toxicity MH - Female MH - Humans MH - Mice MH - Mice, Transgenic MH - *Protein Biosynthesis MH - Protein Multimerization/*drug effects PMC - PMC7175127 OTO - NOTNLM OT - Alzheimer's disease OT - Abeta amyloid OT - amyloid precursor protein OT - copper OT - cytokine OT - neuroinflammation COIS- The authors declare no conflict of interest. EDAT- 2020/03/12 06:00 MHDA- 2021/03/19 06:00 PMCR- 2020/03/01 CRDT- 2020/03/12 06:00 PHST- 2020/02/13 00:00 [received] PHST- 2020/03/02 00:00 [revised] PHST- 2020/03/04 00:00 [accepted] PHST- 2020/03/12 06:00 [entrez] PHST- 2020/03/12 06:00 [pubmed] PHST- 2021/03/19 06:00 [medline] PHST- 2020/03/01 00:00 [pmc-release] AID - biom10030408 [pii] AID - biomolecules-10-00408 [pii] AID - 10.3390/biom10030408 [doi] PST - epublish SO - Biomolecules. 2020 Mar 6;10(3):408. doi: 10.3390/biom10030408.